Pancreatic Cancer Research

ResearcherNational Cancer Center Research InstituteActive in the last 2 years

Toshikazu Ushijima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3405-7817; OpenAlex author ID A5073677729. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. Co-author DOI 10.1038/s41388-026-03871-0↗
  2. Pancreatic Cancer Cell Fraction Estimation in a DNA Sample. Last author DOI 10.1159/000491637↗
  3. Systemic Administration of Small Interfering RNA Targeting Human Nestin Inhibits Pancreatic Cancer Cell Proliferation and Metastasis. Co-author DOI 10.1097/mpa.0000000000000427↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eunji Hong · 1 shared paper, 2026 · strength 0.22
  2. Ja‐Lok Ku · 1 shared paper, 2026 · strength 0.22
  3. Seong‐Jin Kim · 1 shared paper, 2026 · strength 0.22
  4. Daechan Park · 1 shared paper, 2026 · strength 0.22
  5. Wooil Kwon · 1 shared paper, 2026 · strength 0.22
  6. Kenjiro Kimura · 1 shared paper, 2018 · strength 0.07
  7. Ryosuke Amano · 1 shared paper, 2018 · strength 0.07
  8. Hiroki Ishihara · 1 shared paper, 2018 · strength 0.07
  9. Norifumi Kawada · 1 shared paper, 2018 · strength 0.07
  10. Kosei Hirakawa · 1 shared paper, 2018 · strength 0.07
  11. Hisashi Yoshimura · 1 shared paper, 2016 · strength 0.07
  12. Yoko Matsuda · 1 shared paper, 2016 · strength 0.07
  13. Tomio Arai · 1 shared paper, 2016 · strength 0.07
  14. Toshiyuki Ishiwata · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.